Literature DB >> 2901850

Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.

Y Sidi1, C Panet, L Wasserman, A Cyjon, A Novogrodsky, J Nordenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901850      PMCID: PMC2246497          DOI: 10.1038/bjc.1988.162

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  16 in total

1.  Use of mycophenolic acid in superifical bladder cancer.

Authors:  J G Connolly; G M Halsall
Journal:  Urology       Date:  1975-01       Impact factor: 2.649

Review 2.  Enzymology of cancer cells (second of two parts).

Authors:  G Weber
Journal:  N Engl J Med       Date:  1977-03-10       Impact factor: 91.245

3.  Experimental antitumor activity and preclinical toxicology of mycophenolic acid.

Authors:  M J Sweeney; K Gerzon; P N Harris; R E Holmes; G A Poore; R H Williams
Journal:  Cancer Res       Date:  1972-09       Impact factor: 12.701

4.  Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.

Authors:  J B Gibbs; I S Sigal; M Poe; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

5.  Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations.

Authors:  S Sukumar; V Notario; D Martin-Zanca; M Barbacid
Journal:  Nature       Date:  1983 Dec 15-21       Impact factor: 49.962

6.  Sodium butyrate produces concordant expression of "early placental" alkaline phosphatase, pregnancy-specific beta 1-glycoprotein and human chronic gonadotropin beta-subunit in a newly established uterine cervical cancer cell line (SKG-IIIa).

Authors:  S Nozawa; E Engvall; S Kano; S Kurihara; W H Fishman
Journal:  Int J Cancer       Date:  1983-09-15       Impact factor: 7.396

7.  Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells.

Authors:  Y S Kim; D Tsao; B Siddiqui; J S Whitehead; P Arnstein; J Bennett; J Hicks
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

8.  Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.

Authors:  D L Lucas; H K Webster; D G Wright
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

9.  Enzymes of purine metabolism in cancer.

Authors:  G Weber
Journal:  Clin Biochem       Date:  1983-02       Impact factor: 3.281

10.  The inhibition of nucleic acid synthesis by mycophenolic acid.

Authors:  T J Franklin; J M Cook
Journal:  Biochem J       Date:  1969-07       Impact factor: 3.857

View more
  6 in total

1.  Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene.

Authors:  J J Gu; S Stegmann; K Gathy; R Murray; J Laliberte; L Ayscue; B S Mitchell
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Effects of differentiation-inducing agents on purine nucleotide metabolism in an ovarian cancer cell line.

Authors:  E Zoref-Shani; R Lavie; Y Bromberg; E Beery; Y Sidi; O Sperling; J Nordenberg
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.

Authors:  Jörg Fellenberg; Pierre Kunz; Heiner Sähr; Daniela Depeweg
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

4.  Tyrphostins reduce chemotherapy-induced intestinal injury in mice: assessment by a biochemical assay.

Authors:  Y Zlotnik; M Patya; A Vanichkin; A Novogrodsky
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

5.  High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma.

Authors:  Yi Xu; Zhousan Zheng; Ying Gao; Shiyu Duan; Cui Chen; Jian Rong; Kebing Wang; Miao Yun; Huiwen Weng; Sheng Ye; Jiaxing Zhang
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

6.  Novobiocin-induced anti-proliferative and differentiating effects in melanoma B16.

Authors:  J Nordenberg; D Albukrek; T Hadar; A Fux; L Wasserman; A Novogrodsky; Y Sidi
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.